Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Structure Therapeutics
2 articles
Structure Therapeutics Stock 187% Gains: What It Means
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...